This track explores how pharma companies strengthen global product strategies with competitive intelligence, leverage clinical and market data for long-term forecasting, and harness AI to elevate commercial excellence. It also examines how regulatory changes like the U.S. Inflation Reduction Act shape industry dynamics, access, and global market strategies.